Skip to content

Earnings yield at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
3.6%-1.9pp
Stryker logo
StrykerSYK
2.7%+0.6pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-13%-3.9pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
4.3%+0.2pp
Globus Medical logo
Globus MedicalGMED
5%+3.2pp
Alphatec Holdings logo
Alphatec HoldingsATEC
-7.6%-1.9pp

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Calculated from Xtant Medical Holdings’s reported figures.

Based on trailing twelve months.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's earnings yield?
Xtant Medical Holdings (XTNT) reported earnings yield of 2.3% in Q1 2026.
How has Xtant Medical Holdings's earnings yield changed year-over-year?
Xtant Medical Holdings's earnings yield increased by 112.7% year-over-year, from -18.3% to 2.3%.
What is the long-term trend for Xtant Medical Holdings's earnings yield?
Over 4 years (2020 to 2025), Xtant Medical Holdings's earnings yield has grown at a -9.5% compound annual growth rate (CAGR), from -6.8% to 4.5%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.